3.91
Evolent Health Inc stock is traded at $3.91, with a volume of 2.03M.
It is down -2.01% in the last 24 hours and up +73.78% over the past month.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
See More
Previous Close:
$3.99
Open:
$3.93
24h Volume:
2.03M
Relative Volume:
0.66
Market Cap:
$445.81M
Revenue:
$1.88B
Net Income/Loss:
$-534.51M
P/E Ratio:
-0.7595
EPS:
-5.1483
Net Cash Flow:
$4.76M
1W Performance:
+8.01%
1M Performance:
+73.78%
6M Performance:
-38.43%
1Y Performance:
-62.97%
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH vs VEEV, BTSG, TEM, HQY, DOCS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
EVH
Evolent Health Inc
|
3.91 | 454.93M | 1.88B | -534.51M | 4.76M | -5.1483 |
|
VEEV
Veeva Systems Inc
|
171.19 | 27.80B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
BTSG
Brightspring Health Services Inc
|
51.44 | 10.38B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
54.07 | 10.01B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
HQY
Healthequity Inc
|
82.63 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
DOCS
Doximity Inc
|
25.77 | 4.60B | 637.78M | 239.40M | 307.21M | 1.1909 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-25-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Nov-13-25 | Upgrade | Stephens | Equal-Weight → Overweight |
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-03-24 | Reiterated | BTIG Research | Buy |
| Nov-08-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-09-24 | Upgrade | Truist | Hold → Buy |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-01-24 | Initiated | Oppenheimer | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-23 | Initiated | UBS | Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Nov-01-22 | Initiated | Truist | Hold |
| Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-29-21 | Resumed | JP Morgan | Neutral |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
| Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-05-18 | Resumed | Leerink Partners | Outperform |
| Jun-04-18 | Initiated | Piper Jaffray | Overweight |
| Apr-24-18 | Resumed | JP Morgan | Neutral |
| Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-02-17 | Initiated | Robert W. Baird | Outperform |
| Mar-14-17 | Initiated | Oppenheimer | Outperform |
| Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-28-16 | Resumed | JP Morgan | Overweight |
| Aug-05-16 | Reiterated | FBR Capital | Outperform |
| Jul-26-16 | Initiated | Jefferies | Buy |
| Jul-13-16 | Reiterated | FBR Capital | Outperform |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
| Jan-06-16 | Initiated | Canaccord Genuity | Buy |
| Jun-30-15 | Initiated | Goldman | Buy |
| Jun-30-15 | Initiated | JP Morgan | Overweight |
| Jun-30-15 | Initiated | Leerink Partners | Outperform |
| Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
Evolent Health Inc expected to post a loss of 5 cents a shareEarnings Preview - TradingView
MSN Money - MSN
MSN - MSN
Evolent Health (EVH) price target decreased by 32.38% to 6.01 - MSN
XOMA Royalty, Oruka Therapeutics, Repay Holdings And Other Big Stocks Moving Higher On Monday - Sahm
Engaged Capital takes new position in BlackLine, Cognex, lowers stake in Evolent Health in Q3 moves - MSN
Evolent Health Stock Rises on Q4 Earnings Beat and Strong 2026 Revenue Forecast - IndexBox
Why Evolent Health (EVH) Stock Is Up Today - Yahoo Finance
Evolent Health : 2026 Broadridge Broker Notice - marketscreener.com
Executive pay and board refresh in Evolent Health (NYSE: EVH) 2026 proxy - Stock Titan
[ARS] Evolent Health, Inc. SEC Filing - Stock Titan
Spotting Winners: Evolent Health (NYSE:EVH) And Healthcare Technology for Providers Stocks In Q4 - Yahoo Finance
EVH (Evolent Health Inc) beats Q4 2025 EPS forecasts, but shares drop five percent amid mixed investor sentiment.Margin Improvement - UBND thành phố Hải Phòng
Is Evolent Health (EVH) stock forming a breakout today (Risk Aversion) 2026-04-22Real-time Trade Ideas - UBND thành phố Hải Phòng
Evolent Health (EVH) Stock Chart | Q4 2025: Profit SurprisesCommunity Exit Signals - Cổng thông tin điện tử Tỉnh Sơn La
EVH Stock Grinds Higher As Traders Watch Momentum - StocksToTrade
Evolent Health Inc stock (US30050B1017): Why Google Discover changes matter more now - AD HOC NEWS
Evolent Health Inc stock (US30050B1017): Why healthcare tech execution is suddenly worth a closer lo - AD HOC NEWS
EVH Earnings History & Surprises | EPS & Revenue Results | EVOLENT HEALTH INCA (NYSE:EVH) - ChartMill
RBC Capital Maintains Evolent Health(EVH.US) With Hold Rating, Maintains Target Price $3 - Moomoo
Evolent Health Receives 'Moderate Buy' Consensus from Analysts - National Today
EVH Stock Price, Quote & Chart | EVOLENT HEALTH INCA (NYSE:EVH) - ChartMill
CEO Moves: What is Evolent Health Incs 5 year growth outlookGlobal Markets & High Win Rate Trade Tips - baoquankhu1.vn
Inflation Data: Whats next for Evolent Health Inc stockWeekly Trade Recap & Capital Protection Trading Alerts - baoquankhu1.vn
Are short sellers targeting Evolent Health (EVH) Stock | Price at $2.40, Up 3.22%Sector Rotation - Xã Vĩnh Công
Is Evolent Health (EVH) Stock Testing Resistance | Price at $2.40, Down 1.64%Market Analysis - Xã Vĩnh Công
Tudor Investment Corp Boosts Stake in Evolent Health - National Today
RBC Capital Lowers Price Target for Evolent Health (EVH) by 40% - GuruFocus
Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026 - Sahm
Evolent To Release First Quarter 2026 Financial Results on Thurs - GuruFocus
Astrana Health, Evolent Health, Neogen, agilon health, and Fortrea Shares Are Soaring, What You Need To Know - Yahoo Finance
Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026 – Company Announcement - Financial Times
Evolent Health (EVH): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Trend Review: Whats Evolent Health Incs historical return2026 PreEarnings & Real-Time Volume Triggers - baoquankhu1.vn
Context Capital Management, LLC's Evolent Health Inc(EVH) Holding History - GuruFocus
EVH Stock Analysis: Evolent Health Inc Healthcare Play at 2.25 With Mild Daily Gain - UBND thành phố Hải Phòng
Evolent Health, Inc. (9EH.F) stock price, news, quote and history - Yahoo Finance Singapore
Chart Watch: Is Evolent Health Inc stock a top performer YTD2026 Big Picture & Safe Capital Allocation Plans - baoquankhu1.vn
What is Evolent Health Incs 5 year growth outlookMarket Weekly Review & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Can Evolent Health Inc continue delivering strong returns2026 Trends & Community Trade Idea Sharing - baoquankhu1.vn
Smart Money: Can Evolent Health Inc continue delivering strong returnsWeekly Investment Report & Verified Momentum Stock Alerts - baoquankhu1.vn
Market Sell-Off: Stocks Drop on Geopolitical Uncertainty and Oil Price FearsNews and Statistics - IndexBox
Evolent Health Receives $6.04 Average Price Target from Analysts - National Today
Evolent Health Inc Stock (EVH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):